Practical Guide to Clazosentan Administration in Patients with Aneurysmal Subarachnoid Hemorrhage - PubMed
2 days ago
- #endothelin receptor antagonist
- #delayed cerebral ischemia
- #cerebral vasospasm
- The article is a practical guide for administering clazosentan in patients with aneurysmal subarachnoid hemorrhage (SAH).
- Clazosentan is an endothelin receptor antagonist used to prevent cerebral vasospasm and delayed cerebral ischemia (DCI).
- The guide focuses on postoperative management strategies to optimize outcomes following SAH.
- It involves collaboration from the SAH/Spasm Symposium, reflecting a consensus among neurosurgeons and specialists.
- The text provides clinical recommendations based on current evidence and expert opinion for safe and effective use.